The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMerchants Trust Regulatory News (MRCH)

Share Price Information for Merchants Trust (MRCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 555.00
Bid: 553.00
Ask: 554.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.181%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 555.00
MRCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on The Merchants Trust

24 Mar 2022 07:00

RNS Number : 8055F
Merchants Trust PLC
24 March 2022
 

 

London, UK, 24 March 2022

 

Edison issues review on The Merchants Trust (MRCH)

The Merchants Trust (MRCH) is managed by Allianz Global Investors' chief investment officer, UK equities, Simon Gergel. He is very pleased by how the trust's income has recovered as companies have returned to paying dividends. With an uncertain economic and investment backdrop, which has been exacerbated by the Russian invasion of Ukraine, the manager stresses the importance of focusing on companies' long-term prospects. Gergel considers MRCH's balanced portfolio of attractively valued cyclical and defensive stocks, with both domestic and international businesses, is relatively well positioned for the current environment. The trust has a commendable performance track record, having outperformed its UK benchmark over the last one, three, five and 10 years, while its NAV total return now ranks first or second versus its 16 largest peers in the AIC UK Equity income sector over the last one, three and five years.

MRCH's shares are currently trading at a 1.8% premium to NAV, which compares to a range of an average 0.5% premium to a 2.0% discount over the last one, three, five and 10 years. Strong investor demand for the trust's shares has meant that the share base increased by 5.6% in FY22, and by a further 1.5% so far in FY23. MRCH is on track to deliver 40 consecutive years of dividend growth and offers an attractive, above-market 4.8% yield.

 

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Sarah Godfrey +44 (0)20 3681 2519 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAJJMATMTITBTT
Date   Source Headline
26th Apr 20241:51 pmRNSNet Asset Value(s)
25th Apr 202412:53 pmRNSNet Asset Value(s)
24th Apr 20241:51 pmRNSNet Asset Value(s)
23rd Apr 202412:44 pmRNSNet Asset Value(s)
22nd Apr 20241:13 pmRNSNet Asset Value(s)
19th Apr 202412:45 pmRNSNet Asset Value(s)
18th Apr 20241:24 pmRNSNet Asset Value(s)
17th Apr 20242:30 pmRNSNet Asset Value(s)
16th Apr 20244:28 pmRNSDirector/PDMR Shareholding
16th Apr 20241:10 pmRNSNet Asset Value(s)
15th Apr 202412:21 pmRNSNet Asset Value(s)
12th Apr 20241:11 pmRNSNet Asset Value(s)
11th Apr 20241:01 pmRNSNet Asset Value(s)
10th Apr 202412:55 pmRNSNet Asset Value(s)
9th Apr 20241:20 pmRNSNet Asset Value(s)
8th Apr 202412:43 pmRNSNet Asset Value(s)
5th Apr 20241:57 pmRNSNet Asset Value(s)
5th Apr 20241:26 pmRNSDividend Declaration
5th Apr 202410:00 amRNSGeographical Distribution
4th Apr 20244:41 pmRNSTotal Voting Rights
4th Apr 20244:38 pmRNSTop 10 Holdings
4th Apr 20243:24 pmRNSNet Asset Value(s)
4th Apr 20249:45 amRNSListing Rule 15.6.8
4th Apr 20247:00 amRNSFinal Results
3rd Apr 20241:57 pmRNSNet Asset Value(s)
2nd Apr 20244:00 pmRNSNet Asset Value(s)
28th Mar 20241:15 pmRNSNet Asset Value(s)
27th Mar 202411:53 amRNSNet Asset Value(s)
26th Mar 202412:31 pmRNSNet Asset Value(s)
25th Mar 202412:10 pmRNSNet Asset Value(s)
22nd Mar 20244:31 pmRNSBlock listing Interim Review
22nd Mar 202412:52 pmRNSNet Asset Value(s)
21st Mar 202412:19 pmRNSNet Asset Value(s)
20th Mar 202412:41 pmRNSNet Asset Value(s)
19th Mar 20241:04 pmRNSNet Asset Value(s)
18th Mar 202412:49 pmRNSNet Asset Value(s)
15th Mar 20241:06 pmRNSNet Asset Value(s)
14th Mar 20241:30 pmRNSNet Asset Value(s)
13th Mar 20241:02 pmRNSNet Asset Value(s)
12th Mar 20241:01 pmRNSNet Asset Value(s)
11th Mar 202412:29 pmRNSNet Asset Value(s)
8th Mar 20241:24 pmRNSNet Asset Value(s)
7th Mar 20243:25 pmRNSClosed Period
7th Mar 20242:35 pmRNSGeographical Distribution
7th Mar 20242:00 pmRNSNet Asset Value(s)
7th Mar 20241:56 pmRNSTop 10 Holdings
6th Mar 202412:49 pmRNSNet Asset Value(s)
5th Mar 20242:35 pmRNSNet Asset Value(s)
4th Mar 20241:56 pmRNSNet Asset Value(s)
1st Mar 20244:08 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.